Sobetirome: A Selective Thyromimetic for the Treatment of Dyslipidemia

E-ISSN： 2212-3962|6|1|16-19

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.6, Iss.1, 2011-01, pp. : 16-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies for management and treatment of dyslipidemia in HIV/AIDS

By Sax P. E.

AIDS Care, Vol. 18, Iss. 2, 2006-02 ,pp. : 149-157

Routledge Ltd

Access to resources Recommend Favorite

Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease

By Poussa Heikki Strandberg Timo E. Tikkanen Ilkka Kauhanen Petteri Lepäntalo Mauri

Scandinavian Cardiovascular Journal, Vol. 41, Iss. 3, 2007-01 ,pp. : 138-141

Informa Healthcare

Access to resources Recommend Favorite

Ursodeoxycholic Acid for Treatment of Fatty Liver Disease and Dyslipidemia in Morbidly Obese Patients

Digestive Diseases, Vol. 29, Iss. 1, 2011-06 ,pp. : 117-118

Karger

Access to resources Recommend Favorite

Cholesterol: The Good, the Bad, and the Ugly - Therapeutic Targets for the Treatment of Dyslipidemia

Medical Principles and Practice, Vol. 23, Iss. 2, 2013-12 ,pp. : 99-111

Karger

Access to resources Recommend Favorite

A New Perspective in the Treatment of Dyslipidemia: Can Fenofibrate Offer Unique Benefits in the Treatment of Type 2 Diabetes Mellitus?

By Steiner George

Treatments in Endocrinology, Vol. 4, Iss. 5, 2005-01 ,pp. : 311-317

Adis International

Access to resources Recommend Favorite